Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Solving staphylococcal resistance to beta-lactams.

Henry F Chambers1

  • 1Department of Medicine, Division of Infectious Diseases, San Francisco General Hospital, Box 0811, 3rd and Parnassus Avenues, San Francisco, CA 94110, USA. chipc@itsa.ucsf.edu

Trends in Microbiology
|April 23, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin Structure Infections.

Open forum infectious diseases·2026
Same author

Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and clinical implications in the prospective observational <i>Pseudomonas</i> study.

Antimicrobial agents and chemotherapy·2026
Same author

Pharmacokinetics of Dalbavancin in Complicated Staphylococcus aureus Bacteremia: A Secondary Analysis of the DOTS Randomized Clinical Trial.

JAMA network open·2026
Same author

A patient-centric paradigm and tool for clinical research: the DOOR is open.

Antimicrobial agents and chemotherapy·2025
Same author

Study protocol for a multicenter, multinational prospective randomized controlled trial comparing outcomes in subjects with Gram-negative bacteremia who have blood culture evaluation using Fast Antibiotic Susceptibility Testing vs. standard of care testing: the FAST trial.

Trials·2025
Same author

Spatial clusters of dominant lineages of uropathogenic Escherichia coli in a community dwelling patient population.

BMC infectious diseases·2025
Same journal

Host membranes provide hidden gateways for 'accidental pathogens'.

Trends in microbiology·2026
Same journal

Structural inequalities in global antimicrobial resistance governance.

Trends in microbiology·2026
Same journal

Environmental microbes as modulators of plant volatile landscapes: Implications for plant-insect chemical communication.

Trends in microbiology·2026
Same journal

Beyond AMGs: Phage-encoded transcription and sigma factors as understudied virocell reprogramming tools.

Trends in microbiology·2026
Same journal

Cronobacter spp.

Trends in microbiology·2026
Same journal

Anaerobic lignin deconstruction: A game changer for lignocellulosic biorefineries.

Trends in microbiology·2026
See all related articles

Gram-positive bacteria resist beta-lactam antibiotics through structural changes in penicillin-binding proteins (PBPs). Understanding the structure of PBP2a in staphylococci can help design new antibiotics to overcome this resistance.

Area of Science:

  • Microbiology
  • Structural Biology
  • Medicinal Chemistry

Background:

  • Beta-lactam antibiotics are crucial for treating bacterial infections.
  • Resistance to beta-lactams in Gram-positive bacteria is a growing public health concern.
  • Penicillin-binding proteins (PBPs) are the targets of beta-lactam antibiotics.

Purpose of the Study:

  • To elucidate the structural basis of beta-lactam antibiotic resistance mediated by PBP2a in staphylococci.
  • To identify specific molecular interactions responsible for resistance.
  • To provide insights for designing novel beta-lactam antibiotics that overcome existing resistance mechanisms.

Main Methods:

  • X-ray crystallography was used to determine the three-dimensional structure of PBP2a.
  • Structural analysis focused on the active site and its interactions with beta-lactam antibiotics.

Related Experiment Videos

  • Comparative structural analysis with susceptible PBPs was performed.

    • Main Results:

    • The crystal structure of PBP2a, a low-affinity PBP, was determined.
    • Specific structural features and molecular interactions conferring resistance were identified.
    • These structural impediments make antibiotic binding energetically unfavorable, leading to resistance.

    Conclusions:

    • The determined structure of PBP2a provides a molecular understanding of staphylococcal beta-lactam resistance.
    • This knowledge can guide the rational design of new beta-lactam antibiotics effective against resistant strains.
    • Targeting these structural impediments may lead to the development of next-generation antibiotics.